- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Hospira Inc. (NYSE:HSP) has been removed from U.S. Focus List at Bank of America Merrill Lynch.
Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) target has been raised by Roth Capital following the company’s report of statistically significant Phase IIb survival data for bavituximab in 2nd line NSCLC. The firm continues to be highly encouraged by the data, and it keeps a Buy rating on the stock. It continues to name Peregrine as a Focus Pick.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.